ONCOGENE AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−2,1 mill kr).
- Nylig endring 2026-04-28 Aksjekapital registrert 2026-04-28.
ONCOGENE AS is registered as a limited company in Lillestrøm, Akershus with organisation number 825818642. The business is classified under technical testing and analysis (NACE 71.200). The company was incorporated in 2020. Registered share capital is NOK 32,000, divided into 319 shares. The company's stated purpose is: “Tilby genetiske analyser for privatpersoner, forskning og annen næringsvirksomhet, samt bioinformatikk analyse av alle slag for presisjonsmedisin og personalisert terapi, og annet som naturlig faller sammen med dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 1.2m in revenue and NOK −2.1m in operating profit.
Former names: SEQ DISCOVERY AS
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns ONCOGENE AS?
ONCOGENE AS has 6 registered shareholders:
- MODUS I AS 72.0%
- ECONTO AS 10.0%
- IDA CHRISTINE FILTENBORG HANSEN 5.0%
- TORE HELGE RISMYHR 5.0%
- MAKRI INVEST AS 5.0%
- BINITA DEBNATH 3.0%
Frequently asked questions about ONCOGENE AS
Who owns ONCOGENE AS?
MODUS I AS is the largest registered owner, with 72.0%.
What is the revenue of ONCOGENE AS?
ONCOGENE AS had revenue of NOK 1.2m in 2025.
Who is the general manager of ONCOGENE AS?
Morten Bjelke-Holtermann Duesund is registered as general manager of ONCOGENE AS.
Where is ONCOGENE AS based?
ONCOGENE AS has its business address in Kjeller.
Property
5 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.